RNAa | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

836 results for “RNAa”

Trials

View all 412 →

Risankizumab Long-term Remission Study

24 participants · First posted Nov 16, 2020

A Phase I Open Label Dose Escalation Trial of RNA-144101 in the Treatment of Geographic Atrophy

First posted Mar 25, 2010

Major Depression and Messenger RNAs

30 participants · First posted Oct 20, 2009

Drugs

View all 176 →

prNP-RNA3

prNP-RNA2

prNP-RNA1

Organizations

Rna Diagnostics, Inc.

Canada

RNA Pharma, LLC

United States

BioNTech RNA Pharmaceuticals GmbH

Germany

News

View all 245 →

MiNA Therapeutics Reports Breakthrough Pre-Clinical Results for RNA-Based Sickle Cell Disease Treatment

FDA Grants Orphan Drug and Rare Pediatric Disease Designations for Duchenne Muscular Dystrophy Therapies

Ractigen's RAG-18 Receives FDA Orphan Drug Designation for Duchenne and Becker Muscular Dystrophy

Page 1 of 84